More importantly, 70 variants are exclusive to the Brazilian sample, including 11 variants in genes related to type I interferon (INF) immunity to influenza virus9, six in candidate genes for COVID-19 response identified by GWAS11, and five related to SARS-CoV-2 entry into lung cells and virus replication2,10. The gene discussed is CBLIF; the disease is COVID-19.